References
Coit D, Ariyan C. MelMART Trial: it’s now or never. Ann Surg Oncol. 2018;25(9):2493–5.
Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902–8.
Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol. 1997;37(3):422–9.
Swetter SM, Thompson JA, Albertini MR, et al. NCCN® Guidelines Insights: Melanoma: Cutaneous, Version 2.2021: Featured Updates to the NCCN Guidelines. J Natl Compr Cancer Netw. 2021;19(4):364–76.
Moncrieff MD, Gyorki D, Saw R, et al. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study. Ann Surg Oncol. 2018;25(9):2541–9.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
DISCLOSURE
The authors declare they have no conflicts of interest and nothing to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rossi, A.J., Verbus, E.A., Faries, M.B. et al. A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II). Ann Surg Oncol 29, 4050–4051 (2022). https://doi.org/10.1245/s10434-022-11766-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-11766-z